Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|April 2, 2014
- Pharmaceutical Technology-04-02-2014
- Volume 38
- Issue 4
SyncOperations Software Helps Increase Workflow
Author(s)Melanie Sena
SyncOperations Software Helps Increase Workflow
Synchrono, a manufacturing software solutions company, launched SyncOperations, a software that offers manufacturers the ability to monitor and synchronize data from all equipment and processes in real time. According to the company, this will allow faster automation of workflow and the ability to track and improve performance, availability, and quality. SyncOperations serves as a real-time data historian that collects and analyzes data from both the machine level and from disparate company systems to offer production professionals, process engineers, and continuous improvement teams an improved path to actionable information. SyncOperations also integrates with SyncManufacturing, the company’s planning, scheduling, and execution system, as well as SyncKanban, an inventory replenishment software for adjustments and full synchronization of the manufacturing operation and extended supply chain.
Synchrono
Articles in this issue
over 12 years ago
Drug Encapsulation for Patient-Centric Dosingover 12 years ago
The Benefits of eClinical Systems in Supply-Chain Managementover 12 years ago
Navigating the Regulatory Landscape of Combination Productsover 12 years ago
Publishing Beyond the Printed Pageover 12 years ago
Global Instability Affects the Pharma Market in BrazilRelated to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
Can Continuous Tableting End Scale-Up for Complex Oral Drugs?
3
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
4
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
5